We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Genomic tools for Psilocybe cubensis propagation
Webinar

Genomic tools for Psilocybe cubensis propagation

On-Demand
Kevin McKernan, CSO at Medicinal Genomics will be joining us to discuss genetic variation in the Psilocybe cubensis synthesis pathway and the design of qPCR assays for simultaneous quantification of E. coli and Salmonella species contamination concurrent with Psilocybe cubensis species identification.
Comprehensive Analysis of Next-Generation Biologics
Webinar

Comprehensive Analysis of Next-Generation Biologics

On-Demand
New methods, techniques and efficient data analysis software in liquid chromatography-tandem mass spectrometry (LC-MS/MS) hold the key for accelerating the development of NGBs and increasing their availability.
Zooming in on SARS-CoV-2 Replication to Develop Antiviral Therapies
Webinar

Zooming in on SARS-CoV-2 Replication to Develop Antiviral Therapies

On-Demand
Antiviral drugs that slow SARS-CoV-2 replication in patient cells are critical for curbing the pandemic. For RNA viruses such as SARS-CoV-2, genome duplication hinges on RNA polymerase, making the enzyme an ideal therapeutic target for drug development.
Mapping Gene Expression Signatures in the Heart and Lungs of Patients with COVID-19
Webinar

Mapping Gene Expression Signatures in the Heart and Lungs of Patients with COVID-19

On-Demand
These technologies can help identify new strategies to enhance myocardial repair and regeneration through target validation and manipulation.
T Cells in COVID-19 – Translating Research Findings Into Clinical Options
Webinar

T Cells in COVID-19 – Translating Research Findings Into Clinical Options

On-Demand
Analysis of SARS-CoV-2-specific T cells is important in understanding their role during acute disease and in long-term protection. Find out about some of the tools used in T-cell research and the promise they show as a cell therapy for COVID-19.
Advanced Technology To Accelerate Development of Next-Generation Biotherapeutics
Webinar

Advanced Technology To Accelerate Development of Next-Generation Biotherapeutics

On-Demand
Biopharmaceutical companies are transitioning from the development of standard monoclonal antibody therapies to more intricate antibody structures and new genetic medicines. Not only are these molecules more complex, but scientists are also under tremendous pressure to understand molecular liabilities sooner and close the developability gap in a much shorter time frame.
Advertisement